Algo’s taking a break Nice to see share price finally moving in the right direction. It's simply amazing how the share price reacts when the shorts take a pause.
We are almost 8 months into dosing at 5 sites in Turkey. Thats 8 months of dosing potentially 100 patients and zero adverse reactions, this is extremely bullish.
This week people who were holding debt agreed to convert debt to shares which is another very bullish indicator.
I believe the group who have been aggressively shorting for the past two years have finally realized they are playing with fire.
My conservative guess is that each Turkish site has approximately 1,000 potential patients and that equates to 5,000 annually combined. We can assume Arch is extremely conservative and that only 3% are considered suitable for participating. That 3% equates to 150 patients annually which is 12.5 patients per month which at 8 months would equate to 100 patients dosed.
If we were to insert a 5% suitable number dosed we would dose 250 patients annually thus trial would be completed in a 12 month period with 8 months already achieved. 5% I think is also reasonable considering 95% would be considered not suitable.
100 Patients should certainly provide a solid indication on how Metablok is working. Please remember we are dosing at a level 4 times higher then previous trial.
We also have Pontiac trial slated to stsrt late 2024 but I suspect it will be 2025 as Canadian sites are notoriously slow on approvals which we know first had with current Metablok phase 2 trial.